向棕化:在癌症生物学和免疫治疗中,这是一个新的前沿
Ye Yang1, Enqi Zhang1, Xuanli Mao1
1Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Second Clinical Hospital of Wuhan University, Wuhan 430071, China.
Biochimica et biophysica acta. Reviews on cancer
|December 9, 2025
概括
蛋白棕化通过改变新陈代谢,信号传递和免疫规避来调节癌症. 抑制这一过程对癌症治疗和免疫治疗有希望,尽管临床使用仍然存在挑战.
科学领域:
- 生物化学 生化学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 蛋白质棕化,即对蛋白质添加棕酸,是关键的翻译后修改.
- 它动态调节蛋白质的功能,定位和稳定性,影响细胞过程.
- 异常的棕化被越来越多地认为是瘤发展和进展的驱动因素.
研究的目的:
- 审查蛋白质棕化在癌症生物学中的多方面的作用.
- 突出其对代谢重编程,瘤信号和免疫调节的影响.
- 讨论目前针对手掌化的治疗策略和未来的方向.
主要方法:
- 文献综述综合了当前关于癌症中蛋白质棕化酶的研究.
- 分析多学科数据和先进的检测技术 (质谱,成像).
- 对小分子抑制剂的临床前数据的评估,以棕化为向.
主要成果:
- 棕化调节关键的癌症通路 (AKT-mTOR,Wnt/β-catenin) 并稳定免疫检查点 (PD-L1,TIM-3).
- 不调节的脂质代谢有助于瘤中异常的棕化.
- 棕化抑制剂在减少瘤生长和增强免疫治疗方面显示出临床前的有效性.
结论:
- 蛋白质棕化是瘤生长,转移和免疫逃避的关键调节者.
- 准棕化通路为癌症治疗提供了一个有前途的治疗途径.
- 需要进一步的研究来克服选择性,毒性和临床转化耐药性的挑战.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


